{"schema_version":"secwatch.filing_event.v1","accession":"0001133421-24-000004","form_type":"8-K","ticker":"NOC","cik":"0001133421","company_name":"NORTHROP GRUMMAN CORP /DE/","filed_at":"2024-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.484764+00:00","generated_at":"2026-06-06T17:39:58.306962+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Northrop Grumman Q4 net loss $535M on $1.56B B-21 charge; FY23 sales up 7% to $39.3B","bullets":["Q4 net loss of $535M ($3.54 loss per diluted share) vs net income $2.08B ($13.46 EPS) in Q4 2022.","Records $1.56B pre-tax charge on B-21 program LRIP phase; full-year diluted EPS of $13.53 includes B-21 charge of $7.68.","Full-year sales $39.3B (+7% YoY); total backlog rises to record $84.2B with book-to-bill of 1.14.","Segment operating income down 35% to $2.76B; Aeronautics Systems swings to operating loss of $473M.","2024 guidance: expects continued sales & earnings growth; reaffirms free cash flow outlook with >15% CAGR through 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001133421-24-000004","json":"https://secwatch.observer/filing/0001133421-24-000004.json","markdown":"https://secwatch.observer/filing/0001133421-24-000004.md","text":"https://secwatch.observer/filing/0001133421-24-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133421/000113342124000004/0001133421-24-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133421/000113342124000004/noc-20240125.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T17:39:58.306962+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"99de9afba95ada32c2dbfa044965538cc84449c0","claim":"NORTHROP GRUMMAN CORP /DE/ reported the quarter and year ended December 31, 2023 results: revenue $10.6 billion, net income $535 million, EPS $3.54 per diluted share. Guidance reaffirmed.","evidence_excerpt":"Fourth Quarter and Full-Year 2023 Financial Results • Total backlog rises to record $84.2 billion driven by full year book to bill of 1.14 • Q4 Sales increase 6 percent to $10.6 billion; 2023 sales increase 7 percent to $39.3 billion • Company records $1.56 billion pre-tax charge associated with LRIP phase of B-21 program • 2023 Diluted EPS of $13.53, including","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1133421/000113342124000004/0001133421-24-000004-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 31, 2023"},{"label":"Revenue","value":"$10.6 billion"},{"label":"Net income","value":"$535 million"},{"label":"EPS","value":"$3.54 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}